U.S. Patient with Advanced Lung Cancer Stabilized by Novel Immunotherapy Treatment in China
SHANGHAI, March 7, 2026 /PRNewswire/ — Jiahui International Cancer Center (JICC) has stabilized a U.S. patient with advanced non‑small cell lung cancer (NSCLC) and Parkinson’s disease using ivonescimab, a novel immunotherapy currently
